Eric Ridgway
Family Medicine · Riverton, WYNPI 1811073364
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AstraZeneca at 26.4% of the total. Reporting peaked in 2021 at $904 and has fallen 73.6% since, to $239 in 2023. Among family medicine clinicians in WY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$850
- GSK$468
- AbbVie$380
- Novo Nordisk$278
- Lilly USA, LLC$262
- Astellas Pharma US Inc$140
- plus $841 from 11 others
What the payments were for
- Food & beverage$3,10897%
- Education$1123%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 44 | $850 |
| GSK | 30 | $468 |
| AbbVie(2 entities) | 21 | $380 |
| Novo Nordisk | 17 | $278 |
| Lilly USA, LLC | 18 | $262 |
| Astellas Pharma US Inc | 3 | $140 |
| Amarin Pharma, Inc. | 7 | $132 |
| Merck | 9 | $131 |
| Pfizer | 8 | $119 |
| Sanofi-aventis U.S. LLC | 7 | $114 |
| Amgen | 6 | $95 |
| Novartis | 5 | $76 |
| Eisai Inc. | 4 | $70 |
| Bayer | 2 | $38 |
| Ultragenyx Pharmaceutical Inc. | 2 | $29 |
| Sunovion Pharmaceuticals Inc. | 2 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$3,220 in reported general payments places this provider in the 90th percentile of 237 family medicine providers in Wyoming.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorpromazine Hcl | 11 | $5,978 |
| Baclofen | 11 | $755 |
| Metoprolol Tartrate | 12 | $313 |
| Nystatin | 12 | $280 |
| Atorvastatin Calcium | 19 | $272 |
| Metformin Hcl | 14 | $265 |
| Rosuvastatin Calcium | 17 | $208 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Riverton
- Demar HillRiverton$3K
- Daniel BenderRiverton$558
- Joseph SchoeberCasper$176K
- James McLennanCasper$13K
- Karlynn SieversCasper$10K
- Eric LawrenceCasper$7K
- Jonathon MedinaCheyenne$6K
- Carol FischerCheyenne$6K
- Louis RoussalisCasper$5K
- Joseph MickelsonCasper$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.